SARMs are selective androgen receptor modulators and contributes to the growth of muscle mass in humans and is safe to use.
It is mentioned the 12-week course oral intake of 3 mg of the drug leads to a gain of dry muscle mass of 1.4 kg and a reduction in fat mass of 300 grams in the absence of any physical exertion. Lower dosages of the substance led to less pronounced results. The official conclusion of the researchers was as follows: SARMs showed a dose-dependent improvement in overall muscle mass and physical functions, well tolerated. SARMs may be useful for the prevention and / or treatment of muscle catabolism associated with cancer and other chronic diseases. Maybe 1.4 kg of muscle mass in 12 weeks is not so much, but it is officially received and fixed result.
Virtually all selective androgen receptor modulators are available on bosspeptides.com in the form of tablets and do not cause damage to the liver. This is the optimal choice for women, since they have minimal effect on libido, sexual characteristics, cholesterol level in the blood, liver, etc.
A recent published article by the manufacturer of the SARMs warns readers: SARMs is often mistakenly confused with the chemical structure of S-4, also known as Andarine.” The chemical structure of SARMs has not yet been made public.
Continue Reading: RAD-140 vs LGD-4033 Comparison and Breakdown!
The term “selective androgen receptor modulator” (SARM) has been proposed to refer to synthetic androgen agonists that bind to androgen receptors with a high degree of tissue selectivity, designed to prevent the side effects of endogenous androgens. These include preparations such as bicalutamide and flutamide, as well as new compounds Andarin and SARMs, and a number of others.
As a result of daily intake of only 3 mg of the arylpropionamide derivative – SARMs – for 3 months, along with the build-up of muscle mass by 1.4 kg, the volunteers were observed increased strength and endurance without special diets and physical exertion. In this case, only androgen receptors are activated in target tissues, such as muscles and bones, while stimulation of receptors in other organs, for example in the prostate, is not affected, or suppressed. This CAPM has a short half-life in humans – 4 hours. It is noted that its reception does not cause a water retention in the body.
Because of the selective nature of this non-steroidal compound, there are no side effects that are characteristic of hormone replacement therapy. SARMs has an anabolic effect comparable to testosterone. Selective androgen receptor modulators act more selectively and have a high bioavailability, which opens wide prospects for their clinical use. In addition, these compounds show anabolic activity, affecting the androgen receptors responsible for the growth of muscle fibers, which leads to an increase in muscle mass and strength.
Similarly, SARMs was nominated for clinical research as a drug for the treatment of muscle exhaustion.
SARMs is absolutely legal all countries. It is NOT included in the list of potent substances, nor is it a structural analogue. The positive qualities of SARMs and its favorable pharmacological safety profile quickly made it very popular in Europe and America, where it can be purchased in various forms: in the form of tablets, in the form of a solution for oral administration, as a solution for injection.